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THE venom  of  the  snake Bothrops  asper,  the  most
important  poisonous  snake  in  Central  America,
evokes an inflammatory  response, the mechanisms
of which are not well characterized. The objectives of
this  study  were  to  investigate  whether  B.  asper
venom and its purified toxins Ð phospholipases and
metalloproteinase Ð activate the complement system
and  the  contribution  of  the  effect  on  leucocyte
recruitment.  In  vitro chemotaxis  assays  were  per-
formed using Boyden’s chamber model to investigate
the  ability  of  serum  incubated  with  venom  and  its
purified toxins to induce neutrophil migration. The
complement  consumption  by  the  venom  was  eval-
uated using an in vitro haemolytic assay. The impor-
tance  of  complement  activation  by  the  venom  on
neutrophil  migration  was  investigated  in  vivo by
injecting  the  venom  into  the  peritoneal  cavity  of
C5-deficient  mice.  Data  obtained  demonstrated that
serum incubated with crude venom and its purified
metalloproteinase BaPÐ1 are able to induce rat neu-
trophil  chemotaxis,  probably  mediated  by  agent(s)
derived from the complement system. This hypoth-
esis was corroborated by the capacity of the venom to
activate this system in vitro. The involvement of C5a
in  neutrophil  chemotaxis  induced  by  venom-acti-
vated serum was demonstrated by abolishing migra-
tion when neutrophils were pre-incubated with anti-
rat  C5a  receptor  antibody.  The  relevance  of  the
complement system in in vivo leucocyte mobilization
was further demonstrated by the drastic decrease of
this response in C5-deficient mice. Pre-incubation of
serum with the soluble human recombinant comple-
ment  receptor  type  1  (sCR  1)  did  not  prevent  the
response induced  by  the  venom,  but  abolished the
migration  evoked  by  metalloproteinase-activated
serum. These data show the role of the complement
system in bothropic envenomation and the participa-
tion  of  metalloproteinase  in  the  effect.  Also,  they
suggest  that  the  venom  may  contain  other  compo-
nent(s) which can cause direct activation of C5a.
Key  words:  Bothrops  asper snake  venom,  Leucocyte
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Inflammatory reaction
Introduction
The acute inflammatory response is characterized by
an increased passage of fluid and leucocytes, partic-
ularly  neutrophils, out  of  the bloodstream into the
damaged tissue.1,2 Neutrophils are one of the central
inflammatory cells in the first line of host defence.
Their  adhesion  to  endothelial  cells  and  the  sub-
sequent  oriented  transmigration  are  key  events  in
their recruitment during inflammation. Such events
are  controlled  by  a  dynamic  interaction  between
adhesion  molecules  (i.e.  selectins)  expressed  on
leucocytes and the endothelial cells, as well as by a
direct  action  of  secreted  chemotactic  mediators
which bind to the expressing seven transmembrane G
protein coupled receptors.2–5
A local inflammatory reaction is characteristic of
envenomations  by  snakes  of  the  genus  Bothrops,
involving oedema formation and leucocyte mobiliza-
tion.6–10 The mechanisms responsible for  leucocyte
recruitment  in  these  envenomations  are  not  well
described. It has been shown that the accumulation
of leucocytes in animals injected with some Bothrops
sp. venoms is dependent on eicosanoid release7,9,10
and on chemotactic factors derived from the serum.10
The  latter  effect  is  probably  due  to  complement
activation as venoms from crotaline snakes are known
to activate the complement system.11 The pathophy-
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important  poisonous  snake  in  Central  America,12
includes systemic alterations such as blood coagula-
tion  disturbances,13 haemorrhage,  cardiovascular
shock  and  renal  failure,14 besides  prominent  local
tissue damage characterized by myonecrosis, haemor-
rhage  and  an  acute  inflammatory  response.6,14–17
Although,  it  has  been  demonstrated  that  oedema
evoked by the venom is multimediated,18 the mecha-
nisms involved in the local leucocyte accumulation
remain unknown.
The aims of the present study were to investigate
whether B. asper venom (BaV) is involved in comple-
ment activation and to  test whether this activation
with the production of soluble complement anaphyla-
toxins  leads  to  leucocyte  recruitment.  Our  results
show that the venom is able to activate classical and
alternative complement system pathways, generating
C5a  component.  Serum  treated  with  BaV  was  a
chemoattractant to neutrophils and we were able to
confirm, as expected, that C5a mediated this effect.
Indeed, an anti-rat C5a receptor (anti-ratC5aR) neu-
tralized the chemotaxis activity. We propose that the
metalloproteinase  BaP–1  present  in  the  venom  is
involved in complement activation. It remains to be
tested whether complement activation can be attrib-
uted solely to this metalloproteinase or whether other
components of the venom have synergistic actions.
Materials and methods
Chemicals and reagents
Crystalline bovine serum albumin (fraction V), eosin Y,
lipopolysaccharide (LPS) from Escherichia coli (ser-
otype 026:B6),  oyster glycogen  type  II,  Sepharose–
polymyxin B columns were purchased from Sigma (St
Louis, MO, USA). Ester cellulose filters (0.22mm and
8.0mm) were from Millipore (Brazil). Liquemine was
acquired from Roche (Brazil).
Blood, sera, antibodies and other proteins
Normal  sheep  and  rabbit  blood,  collected  1:1  in
Alsever’s  old  solution  (pH  6.1,  114 mM  citrate,
27 mM glucose, 72 mM NaCl), was obtained from the
animal  facilities  of  Institute  Butantan  and  stored at
4°C.  Normal human  or  rat  blood  was  obtained in-
house.  Blood  samples  drawn  to  obtain  sera  were
collected without anticoagulant and allowed to clot
for 1h at room temperature (RT). The normal human
serum (NHS) or normal rat serum (NRS) were stored
at –80°C. Anti-rat C5aR antiserum was produced in-
house (P. Gasque) by injecting a rabbit with a multiple
array  C5a  peptide  (amino  acids  12–35:
TYDYSDGTPNPDMPADGVYIPKME)  corresponding
to the N-terminal of the receptor involved in the C5a
binding. The  IgG  fraction  was  obtained  by  affinity
purification on a protein A Sepharose column (Prosep
A, Bioprocessing, Princeton, NJ, USA). The rabbit anti-
C5aR stained specifically rat monocyte cell line NR83/
83  and  rat  C5aR-transfected CHO  cells  (P.  Gasque,
unpublished observation). Soluble recombinant com-
plement receptor type 1 (sCR 1) was obtained from
Avant Immunotherapeutics (Needham, MA, USA).
Venom and purified toxins
Lyophilized crude BaV was a pool obtained from more
than  50  adult  specimens  collected  in  the Atlantic
region of Costa Rica and kept at the Serpentarium of
Instituto Clodomiro Picado, Costa Rica. The venom
was  lyophilized  and  maintained  at  –20°C  and  dis-
solved  at  the  moment  of  use.  Prior  to  the  experi-
ments, the venom solutions were filtered through a
cellulose  ester membrane  of  0.22mm  average  pore
size.  Phospholipase  A2 myotoxins  II  and  III  and
haemorrhagic metalloproteinase BaP–1 were purified
from  crude venom  as previously  described.19–21 In
some experiments, BaV was loaded on to a Sephar-
ose–polymixin  B  column  in  order  to  remove  any
traces of LPS which could be present in the venom.
Animals
Male Wistar rats weighing 170–190g were obtained
from  “Biot´ erio  Central  do  Instituto  Butantan”  and
male  B10/A  (H–2a)  and A/J  (H–2a)  isogenic  mice
strains  weighing  17–20g  were  obtained  from “Bio-
t´ erio  de  Camundongos  isogˆ enicos  do  Instituto  de
Ciˆ encias  Biom´ edicas  da  Universidade  de  S˜ ao  Paulo
(S˜ ao Paulo, SP. Brazil)”. The animals were maintained
with free access to standard rat food pellets and water
ad libitum.
Haemolytic assay
In  order to  assess the  capacity of  BaV  and  related
toxins to activate the complement system in vitro,
samples of NHS were incubated with different con-
centrations of  venom  or  toxin  for  30min  at  37°C.
Control  samples  were  incubated  with  phosphate-
buffered solution (PBS, pH 7.2, containing 10 mM Na
phosphate,  150 mM  NaCl)  alone.  The  haemolytic
assays were performed in  96-well  microtitre plates.
Sheep erythrocytes (Es) were sensitized with rabbit
antibodies  against  Es (1:1000)  for  30min  at  37°C.
Aliquots (100ml) of sensitized cells [2% suspension in
veronal-buffered  saline  (VBS++,  pH  7.4,  containing
10 mM  Na  barbitone,  0.15 mM  CaCl2 and  0.5 mM
MgCl2)]  were  incubated  with  dilutions  of  NHS
(100ml)  as  a  source  of  complement  for  60min  at
37°C. The plates were centrifuged to remove intact
cells  and  the  absorbance  of  the  supernatant  was
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used as the standard for lysis and water-lysed E were
used  as  the  standard  for  100%  lysis.  Alternative
pathway complement activation was measured using
serum  diluted  in  VBS  containing  ethylene  glycol
tetraacetic acid (EGTA)-Mg++ (VBS plus EGTA 0.1M
MgCl2 and 0.1M EGTA) and non-antibody sensitized
rabbit E (Er) as target cells.
Neutrophil preparations
Neutrophils were obtained from  normal Wistar rats
4h after the intraperitoneal injection of 20ml of a 1%
oyster  glycogen  solution  in  PBS. The  animals  were
anaesthetized with ether and the cells collected by
rinsing  the  abdominal  cavity  with  Hanks’  balanced
solution (HBSS,  containing  138 mM NaCl, 5.36 mM
KCl, 1.25 mM Na2HPO4.  12H20, 0.44 mM KH2PO4,
2.94 mM NaHCO3, 0.13 mM CaCl2, 0.1 mM MgSO4,
5.5 mM  glucose)  plus  1U/ml  heparin. Cell viability
was assessed by the eosin Y exclusion test. The final
cell  suspensions  contained  1%  crystalline  bovine
serum albumin in HBSS.
Neutrophil chemotaxis assay
The migration assay was performed as described by
Boyden22 and Zigmond and Hirsch23 using a multi-
well  chemotaxis chamber.  In  brief,  aliquots  of  cell
suspensions  containing 1.5 ´ 106 neutrophils were
added to  the  upper  compartment  of  the  chamber
separated from the chemotactic agent(s) in the lower
compartment  by  an  ester  cellulose  filter  (8mm
average pore size). The chemotactic agent was substi-
tuted for HBSS for assessment of random migration.
The experiments were performed to evaluate: (1) the
capacity of BaV to directly induce neutrophil chem-
otaxis, (2) the neutrophil chemotaxis in response to
serum  pre-treated  with  BaV  (see  below),  (3)  the
capacity of myotoxins II or III and metalloproteinase
BaP–1 to generate chemotactic factors derived from
serum,  (4)  the  participation  of  C5a/C5aR  in  the
chemotaxis event. Activated serum was obtained by
incubation with E. coli LPS (65mg/ml) for 30min at
37°C. Varying concentrations of LPS-activated serum
were prepared using HBSS as the diluent.
The  chemotaxis  chambers  were  incubated  in
humidified  air  at  37°C  for  60min,  followed  by
removal of the filters for fixation and staining of the
cells.  Neutrophil  migration  within  the  filter  was
determined under light microscopy by  the “leading
front” method,23 in which the distance was measured
from the top of the filter to the farthest plane of focus
still  containing  two  cells  observed  with  the  ´ 40
objective. Five fields were counted and averaged for
each  experiment,  which  was  performed  in
duplicate.
Determination of the number and specific cell
type of leucocytes of peritoneal exudate
following BaV injection
To evaluate  leucocyte recruitment induced  by  BaV,
10mg of venom dissolved in 1ml of sterile saline was
injected into the peritoneal cavity of  B10/A (H–2a;
C5-sufficient)  and A/J  (H–2a;  C5-deficient)  isogenic
mice  strains  under  light  ether  anaesthesia.  Match
controls of each group  of  animals received 1ml  of
sterile saline by the same route. After 4h, the animals
were  re-anaesthetized  with  ether,  the  abdominal
cavity was opened, and the exudate was withdrawn
after  washing  the  peritoneum  with  3ml  of  PBS
containing  5U/ml  heparin. Total  leucocyte  counts
were performed on Neubauer chambers and differ-
ential counts on smears stained with panchromatic
dye.
Analysis of data
Means and standard error of the mean (SEM) of all
data are presented and compared by Student’s t-test or
analysis of variance. When appropriate, the data were
analysed by the Newman–Keuls test.24
Results
Activation and consumption of the haemolytic
activity of the complement system following
treatment with BaV
The effect of BaV on the activity of the complement
system  was  determined  in  vitro,  using  NHS  as  a
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FIG.  1.  Consumption  of  the  haemolytic  activity  of  the
complement  system  following  treatment  with  Bothrops
asper venom (BaV). Samples of normal human serum (NHS)
were incubated with different concentrations of venom for
30min at 37°C. Control samples were incubated with phos-
phate-buffered solution (PBS) alone. Classical pathway (CP)
activation of  the  complement  system  was  determined by
incubating aliquots of EA with dilutions of NHS in veronal-
buffered saline (VBS)  for  60min at 37°C.  The plates were
centrifuged to remove intact cells and the absorbance of the
supernatant was measured at 414nm. Alternative pathway
(AP) activation of the complement system was measured by
using  serum  diluted  in  VBS  containing  EGTA-Mg
++ and
rabbit E as target cells. Values are mean ± standard error (SE)
of three experiments each performed in duplicate.source of complement, with different doses of venom
for 30min at 37°C. The residual complement activity
was determined by haemolytic assays performed in
conditions  for  measuring  classical  or  alternative
pathway activation. Figure 1 shows that BaV induces
a dose-dependent reduction in haemolytic activity as
measured  by  both  classical  and  alternative
pathways.
Leucocyte chemotaxis assay
To  evaluate  the  capacity  of  BaV  per  se to  induce
neutrophil migration, varying doses of venom (1, 10,
50 or 100mg/ml) were dissolved in HBSS and placed
in the bottom compartment of Boyden’s chamber. The
upper  compartment  was  filled  with  neutrophils
suspended in HBSS. The observed neutrophil migra-
tion was equivalent in all doses used, being similar to
that observed in random migration (HBSS) (data not
shown), indicating that BaV has no direct neutrophil
transmigration activity.
In  order  to  investigate  the  influence  of  BaV  on
neutrophil-oriented  migration  capacity,  neutrophils
were incubated with venom (1 ´ 107 cells suspended
in 1, 10, 50 or 100mg BaV/ml in HBSS) for 1h at 37°C,
centrifuged and immediately resuspended in HBSS for
testing. These venom doses did not affect cell viability.
The  results  indicated  that  pre-incubation  with  BaV
does  not  alter  neutrophil  chemotactic response  to
LPS-activated  serum.  The  migration  obtained  with
cells  pre-incubated  with  different  doses  of  BaV  in
response to HBSS, 1 or 10% of LPS-activated serum
were  similar  and  equivalent  to  that  observed with
cells pre-incubated with HBSS (data not shown).
To  investigate  the  ability  of  BaV  to  generate
complement chemotactic factors following  comple-
ment activation, varying doses of venom were incu-
bated with serum for 30min at 37°C, diluted (v/v) in
HBSS and tested in Boyden’s chamber. The migration
observed with serum treated with 1 or 10mg BaV/ml
was similar to that observed with non-treated serum
(data not shown). However, higher doses of venom
(50  or  100mg/ml)  were  able  to  induce  neutrophil
migration  equivalent  to  that  observed  with  LPS-
activated serum (Fig. 2A). This effect is not dependent
on bacterial LPS components present in the venom, as
equivalent  migration was obtained with polymyxin-
treated BaV (serum + BaV = 120 ± 9.22mm, serum +
polymyxin-treated BaV = 109 ± 8.65mm). Heating the
serum for 1h at 56°C prior to the addition of venom
completely abolished the ability to induce neutrophil
chemotaxis (Fig. 2B).
Participation of C5a component on the
neutrophil chemotaxis induced by the venom
In order to evaluate the possible involvement of the
complement-derived  chemotactic  fragment  C5a  in
the  neutrophil  chemotaxis  induced  by  BaV,  rat
neutrophils  were  pre-incubated  for  15min  with
S. H. P. Farsky et al.
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FIG. 2. Chemotactic responses of neutrophils to Bothrops asper venom (BaV) and to lipopolysaccharide (LPS)-treated serum.
Neutrophils were placed in the top compartment of the chamber and allowed to migrate for 1h. (A) BaV and LPS were
incubated with serum for 30min at 37°C, diluted in Hanks’ balanced solution (HBSS) and used as chemotactic agents. (B)
Heating the serum for 1h at 56°C prior to the addition of BaV or LPS prevents its ability to induce neutrophil migration. Values
are mean ± standard error of the mean (SEM) of four experiments each performed in duplicate. *p < 0.01 versus values in the
group using non-activated serum.different dilutions of anti-rat C5a receptor serum and
tested in chemotaxis assays. Figure 3 shows that the
migration  of  neutrophils  was  inhibited  by  anti-rat
C5aR antibody, in a dose-dependent manner. The anti-
C5aR  antibody  was  similar  in  blocking  neutrophil
chemotaxis induced by LPS-activated serum.
Effect of venom phospholipases and
metalloproteinase on the generation of
chemotactic factors from serum
Chemotaxis assays were performed with serum pre-
incubated with different concentrations of phospholi-
pases A2 myotoxin  II  or  III  and  metalloproteinase
BaP–1 at 37°C for 30min. Data obtained showed that
only  metalloproteinase-activated serum  was  able  to
induce neutrophil chemotaxis. The magnitude of the
response induced by 5 or 10mg/ml was equivalent to
that  induced  by  LPS-activated  serum  (Fig.  4).  Pre-
heating the serum at 56°C for 1h abolished the ability
of the metalloproteinase to induce neutrophil chem-
otaxis  (data  not  shown).  Serum  incubated  with
myotoxin II or III (doses of 1, 10, 50mg/ml) did not
induce  in  vitro neutrophil  locomotion  (data  not
shown).
Analysis of the mechanism of C5a generation
in rat serum induced by BaV and
metalloproteinase BaP–1
In  order  to  investigate  the  mechanism  of  comple-
ment  activation  induced  by  the  venom  and  metal-
loproteinase  BaP–1,  normal  serum  was  incubated
with  different  concentrations  of  sCR1  at  37°C  for
5min  before  venom  or  metalloproteinase  addition.
The  same  experimental  procedure  was  performed
on  LPS-activated  serum.  The  solutions  were  incu-
bated  at  37°C  for  30min  and  used  in  chemotaxis
assays. The  results  obtained showed that  sCR1  did
not inhibit the generation of chemotactic factors in
venom-treated serum (Fig. 5). In contrast, sCR1 was
able  to  reduce  the  neutrophil  chemotaxis  serum
activity induced by both metalloproteinase and LPS
(Fig. 5).
Complement system and snake venom
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FIG. 3. Chemotactic responses of neutrophils incubated with different concentrations of anti-rat C5a receptor antibody before
testing with Bothrops asper venom (BaV)-treated and lipopolysaccharide (LPS)-treated serum. Neutrophils were incubated
with the antibody at 37°C for 15min, placed in the top compartment of the chamber and allowed to migrate for 1h. BaV and
LPS were incubated with serum for 30min at 37°C, diluted in Hanks’ balanced solution (HBSS) and used as chemotactic agents.
Values are mean ± standard error of the mean (SEM) of three experiments each performed in duplicate. *p < 0.01 versus values
obtained with incubated serum with HBSS in each group.Local leucocyte mobilization induced by venom
in C5-deficient mice
To evaluate the participation of C5a component on
local leucocyte recruitment induced by BaV, 10mg of
venom  was  injected  into  the  peritoneal  cavity  of
B10/A  (H–2a,  C5-sufficient)  and  A/J  (H–2a,
C5-deficient) isogenic mouse strains and local leuco-
cyte mobilization was determined 4h after envenoma-
tion. The leucocyte mobilization into the peritoneal
cavity  of  the  C5-deficient  animals  was  significantly
reduced (50%) in comparison with that obtained in
the C5-sufficient animals (Fig. 6A). Differential counts
showed no  significant  migration  of  polymorphonu-
clear cells in C5-deficient mouse strain (Fig. 6B).
Discussion
BaV induces pronounced local effects, such as myone-
crosis, haemorrhage and inflammatory reaction, char-
acterized by long-lasting oedema and leucocyte infil-
tration.6,18,25,26 The  mediators  involved  in  the
development of  oedema by  this  venom  have been
partially  studied18 and  the  mechanisms  involved  in
leucocyte recruitment remain unknown. Our results
indicate that BaV activates the complement system
leading  to  the  genesis  of  C5a,  which  is  notably
involved  in  the  chemotaxis  of  neutrophils  during
envenomation.  Metalloproteinases,  such  as  BaP-1,
present in the venom may participate in the effect,
but other component(s) may be involved.
In  vitro chemotaxis  studies  suggest  that  BaV
neither activates neutrophil-specific membrane recep-
tors nor alters the intrinsic mechanisms involved in
leucocyte  locomotion. These  conclusions  are  sup-
ported  by  the  observations  that  venom  per  se is
unable to evoke an oriented cell locomotion and does
not  modify  the  intrinsic  ability  of  neutrophils  to
migrate  in  response  to  a  chemotactic  factor  (LPS-
activated serum). However, BaV was able to generate
chemotactic  factors  when  incubated  with  serum.
Elimination of this activity by heating the serum at
56°C suggests that the serum factor(s) inducing cell
migration may  be  complement  activation products.
Our  observations  of  in  vitro reduction  of  serum
haemolytic  activity  by  the  venom  corroborate this
hypothesis.
It is well known that fragments generated during
complement activation, such as C5a and C5a des arg,
cause neutrophil activation, up-regulation of adhesion
molecules, emigration and chemotaxis.27 C5a is also a
chemotactic factor to monocytes, macrophages, eosi-
nophils and basophils.28 Our results clearly demon-
strate that C5a is involved in both in vitro and in vivo
leucocyte  locomotion  induced  by  BaV.  This  was
clearly  evidenced  by  the  use  of  a  rabbit  antibody
generated against the N-terminal domain of the C5aR
involved in binding activity. These observations were
positively  correlated  with  the  experiments  using
C5-deficient  mice.  In  both  cases,  the  chemotaxis
response was significantly reduced.
The  abolishment  of  local  neutrophil  recruitment
observed  in  C5-deficient  mice  implicates  that  the
complement  system  and  particularly  C5a  act as  an
important  pathogenic  component of  the  inflamma-
tory response following envenomation. Other inflam-
matory  mediators, as  yet uncharacterized, certainly
play  additional  roles  in  the  leucocyte  recruitment
induced  by  BaV  injection. A  role  for  lipoxygenase
pathway-derived products  in  leucocyte  recruitment
after  injections  of  other  Bothrops sp.  venoms  has
already been described.7,9,10 Furthermore, our results
indicate that the  complement  system  has  a  central
role in this phenomenon.
The  presence  of  complement  activators/inactiva-
tors  has  been  demonstrated in  a  variety  of  animal
venoms.11,29–31 Venoms  of  species  classified  in  the
families  Elapidae,  Crotalidae  and Viperidae  contain
components  with  a  broad  range  of  action  on  the
complement system. Some act by cleaving directly a
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FIG.  4.  Chemotactic  responses  of  neutrophils  to  serum
treated  with  Bothrops  asper metalloproteinase  BaP–1  or
with lipopolysaccharide (LPS). Neutrophils were placed in
the top compartment of the chamber and allowed to migrate
for 1h. BaP–1 or LPS were incubated with serum for 30min
at 37°C, diluted in Hanks’ balanced solution (HBSS) and used
as chemotactic agents. Values are mean ± standard error of
the  mean  (SEM)  of  four  experiments  each  performed  in
duplicate. *p <  0.01 versus  values  obtained in  the  group
using non-activated serum.Complement system and snake venom
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FIG. 5. Effect of soluble recombinant complement receptor type 1 (sCR1) on neutrophil chemotaxis induced by Bothrops asper
venom (BaV), metalloproteinase BaP–1 or lipopolysaccharide (LPS)-treated serum. sCR1 was added to serum 5min prior to the
addition of BaV, BaP–1 or LPS. The solutions were incubated at 37°C for 30min, diluted in Hanks’ balanced solution (HBSS) and
used as chemotactic agents. Neutrophils were placed in the top compartment of the chamber. Migration was determined 1h
after incubation of the chamber at 37°C. Values are mean ± standard error of the mean (SEM) of three experiments each
performed in duplicate. *p < 0.001 versus values in the corresponding samples of serum without sCR1.
FIG. 6. Number of total (A) and differential (B) leucocytes migrated into the peritoneal cavity of male B10A (H–2
a) or A/J (H–2
a)
mice 4h after intraperitoneal injection of 10mg of Bothrops asper venom (BaV) dissolved in 1ml of sterile saline. Both groups
of animals received venom or the equivalent volume of sterile saline. Values are mean ± standard error of the mean (SEM) of
five animals in each group. *p < 0.01 versus values obtained in control animals treated with BaV, **p < 0.001 versus values
obtained in control animals treated with saline and ***p < 0.001 versus values obtained in control animals treated with
BaV.particular  component,  while  others  interact  with
complement components with the resulting complex
being  able  to  activate  part  of  the  complement
cascade.
The complement activation induced by  BaV  was
not attributed to the action of bacterial LPS. All venom
solutions were sterilized by filtration and the eventual
contamination by LPS was removed following poly-
myxin  B  column  purification.  Interestingly,  venom-
induced complement activation was not affected by
incubation  of  the  serum  with  sCR  1,  whereas this
soluble  complement  inhibitor  abrogated neutrophil
chemotaxis of LPS-activated serum.
Various tissue-damaging toxins have been isolated
from BaV. There are at least four myotoxic phospholi-
pases  A2 which  induce  acute  muscle  damage  by
directly  affecting  the  integrity  of  the  muscle  cell
plasma  membrane.17 These  myotoxins  also  induce
oedema.17,32 In  addition,  five  haemorrhagic  metal-
loproteinases  have  been  purified  from  this
venom.21,33,34 Besides affecting the integrity of capil-
lary blood vessels,35,36 metalloproteinases also induce
myonecrosis,36,37 skin damage38 and oedema.37
Our results indicate that metalloproteinase BaP–1 is
able to activate the complement system, as shown by
the decrease in the haemolytic activity of the serum
with the  toxin  (data not shown). In  addition, neu-
trophil chemotaxis was evidenced when exposed to
serum  treated  with  BaP–1.  In  contrast,  the  two
myotoxic  phospholipases  A2 did  not  activate  the
complement system nor induce complement-depend-
ent  chemotaxis.  Interestingly,  the  mechanism  of
complement activation by metalloproteinase seems to
be  dependent  on  C3  convertase  assembly,  as  the
addition of sCR 1 to BaP–1-treated serum prevented
the  generation  of  chemotactic factors.  In  contrast,
complement activation by venom does not seem to be
dependent on C3 convertase formation. Hence, sCR1
was unable to inhibit the neutrophil chemotaxis in
response  to  venom-treated  serum,  suggesting  that
specific venom component(s) may act on the comple-
ment system by cleaving directly C5 component to
generate a functional C5a anaphylatoxin fragment.
The  precise  mechanism  by  which  the  venom
induces complement activation and the identification
of other venom component(s) involved in the genera-
tion of C5a are the subjects of further study.
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